Speaker

Andrew is Joint Managing Director at Lightning Health, where he is specialised in supporting the evidence generation, value demonstration and HTA strategy development for innovative medicines. He has extensive experience in Health Economics and Global Market Access, including multiple roles in Health Policy Research and Market Access Consulting.

Andrew obtained his MSc Health Economics from the University of York, and has led a policy review at the Nova School of Business and Economics, Lisbon, regarding European Commission incentives for the development of orphan drugs.